Measurable Residual Disease for CLL by Flow Cytometry (not accredited)
EPTIS factsheet 287270 | Last revision 2022-02-11 | URL: https://www.eptis.bam.de/pts287270 https://www.eptis.bam.de/pts287270
| PT provider | ||||||||||
| PT provider | UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping | |||||||||
| Based in | United Kingdom | |||||||||
| Language(s) | English | |||||||||
| Remarks | Please refer to our website for further information http://www.ukneqasli.co.uk/eqa-pt-programmes/flow-cytometry-programmes/measurable-residual-disease-for-cll-by-flow-cytometry-pilot-not-accredited/ | |||||||||
| Keywords | ||||||||||
| Product groups |
Human test material
|
|||||||||
| Testing fields |
Biology
Medical analysis |
|||||||||
| Technical details | ||||||||||
|
||||||||||
| Aims of the PT scheme | ||||||||||
| Target group of participants | ||||||||||
| Linked to specific legislation / standards | ISO17043:2010 ISO15189:2012 ISO13528:2015 | |||||||||
| Additional, subsidiary aims | ||||||||||
| Number of participants | 60 | |||||||||
| Accredited or otherwise reviewed by a 3rd party | ||||||||||
| Operation is commissioned / requested by | ||||||||||
| Fees and frequency | ||||||||||
| Participation fee | Please contact UKNEQASLI for details | |||||||||
| Regularly operated | Yes (Maximum 4 per annum) | |||||||||
| Year of first operation | 2016 | |||||||||
| Contact details of the PT provider | ||||||||||
| Provider | Contact person | |||||||||
|
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road S10 2QD Sheffield United Kingdom Phone: +44 (0) 114 2673600 Fax: Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk |
Mr Stuart Scott
Phone: +44 (0) 114 2673600 Fax: Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk |
|||||||||
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.